Align Technology, Inc. (NASDAQ:ALGN) is set to announce third quarter earning results on Wednesday 21st October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, ALGN to report 3Q20 income of $ 0.54 per share.
For the full year, analysts anticipate top line of $ 2070.22 million, while looking forward to income of $ 2.40 per share bottom line.
Previous Quarter Performance
Align Technology, Inc. announced loss for the second quarter of $ 0.35 per share, from the revenue of $ 352.31 million. The quarterly revenues declined 41.35 percent compared with the same quarter last year. According to street consensus, ALGN was expected to report 2Q20 loss of $ 0.04 per share from revenue of $ 322.62 million. The top line results outshined analysts by $ 29.69 million or 9.20 percent.
Stock Performance
Shares of Align Technology, Inc. traded up $ 7.76 or 2.37 percent on Tuesday, reaching $ 334.60 with volume of 559.80 thousand shares. Align Technology, Inc. has traded high as $ 339.68 and has cracked $ 327.91 on the downward trend
The closing price of $ 334.60, representing a 155.58 % increase from the 52 week low of $ 127.88 and a 4.77 % decrease over the 52 week high of $ 343.21.
The company has a market capital of $ 26.36 billion and is part of the Healthcare sector and Medical Appliances & Equipment industry.
Conference Call
Align Technology, Inc. will be hosting a conference call at 4:30 PM eastern time on 21st October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.aligntech.com
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as compliance indicators and compensation for tooth eruption; Invisalign Assist treatment, which offers support to dental practitioners throughout the treatment process, including progress tracking; and Invisalign First Phase I and Invisalign First Comprehensive Phase II package for younger patients with early mixed dentition with a mixture of primary/baby and permanent teeth.
